Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381620218> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W4381620218 abstract "Abstract Study question Is the survival rate of a cohort of donor oocytes used for each recipient associated with the outcomes of the cycle? Summary answer Oocyte cryo-survival rates (benchmark = 95-100%, competency = 85-95%, below-competency = 70-85%, and poor = 50-70%) are not associated with embryological outcomes and clinical pregnancy in the first transfer of the cycle. What is known already The use of vitrified-warmed donor oocytes allows overcoming many logistic challenges, but it is hindered by the loss of oocytes due to degeneration after warming. The 2012 Vienna Consensus established the benchmark rate of oocyte survival at 95-100%, competency level at > 85%. Results <85% cryo-survival are considered below competency, and <70% can be considered poor. Below-benchmark rates of survival may not only limit the number of oocytes, but also could translate into lower cycle KPIs. Study design, size, duration We analyzed 2190 vitrified-warmed donor oocyte recipient cycles, encompassing a total 20280 vitrified oocytes from 1036 donors. Cycles were carried out in 6 private IVF units from the same group. Cycles from 2018 to 2022 were included in the analysis. Cycles with PGT-A and spermatozoa from testicular biopsy were excluded. The outcome of the first transfer of each cycle was analyzed. Participants/materials, setting, methods Vitrification was performed using open carriers and two different commercial media (Irvine-Scientific and Kitazato). In all cases, fertilization was carried out by ICSI, and embryos were cultured to the blastocyst stage at low oxygen tension. Blastocysts with good or fair quality (A, B & C by ASEBIR Criteria) were considered usable, and the usable blastocyst rate was the sum of all blastocysts transferred and cryopreserved, divided by the number of zygotes on day1. Main results and the role of chance The mean number of warmed oocytes per cycle was 9.3, with a survival rate of 93.7%. A pairwise comparison of fertilization rates with Bonferroni correction revealed that the benchmark survival rate group had similar results to the 85-95%, 70-85% and the 50-70% groups (95-100%: 73.7%; 85-95: 72.1%, 70-85%: 70.9%, 50-70%: 73.1%, p = 1 in all cases). The usable blastocyst rate was similar between the benchmark survival rate and the 85-95% and 50-70% groups, but higher than the 70-85% group (95-100%: 49.0%; 85-95: 48.5%, p = 1.00; 70-85%: 43.5%, p = 0.012, 50-70%: 51.3%, p = 1.00). Of 1368 Day5, SET, first-attempt transfers, 53.5% had a clinical pregnancy. The mean age of recipients undergoing embryo transfer was 42.6 ± 4.5 years and they had undergone 1.1 ± 1.8 previous IVF cycles. Adjusted-OR of clinical pregnancy was only significantly lowered in comparison to the benchmark survival rate in the 70-85% survival group (OR:0.49; 95%CI:0.34−0.71), but not it in the 50-70% group (OR:1.50, 95%CI: 0.92-2.46) nor the 85-95% group (OR:1.00, 95%CI: 0.70-1.42). The use of a sperm donor was positively correlated with clinical pregnancy (OR:1.39; 95%CI:1.04-1.88). Recipient age, male factor, and number of previous IVF cycles were not correlated with clinical pregnancy. Limitations, reasons for caution Retrospective study. Only open carriers were used for vitrification. Cumulative outcomes were not assessed. Wider implications of the findings Sub-benchmark levels of oocyte cryo-survival were not directly associated with worse laboratory outcomes or clinical pregnancy rates. These results are encouraging for cases with lower cryo-survival and useful to counsel patients in this regard. Nevertheless, striving to meet benchmark cryo-survival rates is essential. Trial registration number Not Applicable" @default.
- W4381620218 created "2023-06-23" @default.
- W4381620218 creator A5006226869 @default.
- W4381620218 creator A5008874976 @default.
- W4381620218 creator A5012683616 @default.
- W4381620218 creator A5036380097 @default.
- W4381620218 creator A5037341893 @default.
- W4381620218 creator A5051509766 @default.
- W4381620218 creator A5072432791 @default.
- W4381620218 creator A5077607640 @default.
- W4381620218 creator A5083646762 @default.
- W4381620218 creator A5087621665 @default.
- W4381620218 creator A5092234858 @default.
- W4381620218 date "2023-06-01" @default.
- W4381620218 modified "2023-10-17" @default.
- W4381620218 title "P-187 Vitrified-warmed donor oocytes’ cryo-survival rate is not associated with subsequent embryological outcomes and clinical pregnancy rate per first transfer" @default.
- W4381620218 doi "https://doi.org/10.1093/humrep/dead093.547" @default.
- W4381620218 hasPublicationYear "2023" @default.
- W4381620218 type Work @default.
- W4381620218 citedByCount "0" @default.
- W4381620218 crossrefType "journal-article" @default.
- W4381620218 hasAuthorship W4381620218A5006226869 @default.
- W4381620218 hasAuthorship W4381620218A5008874976 @default.
- W4381620218 hasAuthorship W4381620218A5012683616 @default.
- W4381620218 hasAuthorship W4381620218A5036380097 @default.
- W4381620218 hasAuthorship W4381620218A5037341893 @default.
- W4381620218 hasAuthorship W4381620218A5051509766 @default.
- W4381620218 hasAuthorship W4381620218A5072432791 @default.
- W4381620218 hasAuthorship W4381620218A5077607640 @default.
- W4381620218 hasAuthorship W4381620218A5083646762 @default.
- W4381620218 hasAuthorship W4381620218A5087621665 @default.
- W4381620218 hasAuthorship W4381620218A5092234858 @default.
- W4381620218 hasBestOaLocation W43816202181 @default.
- W4381620218 hasConcept C105702510 @default.
- W4381620218 hasConcept C126322002 @default.
- W4381620218 hasConcept C160099875 @default.
- W4381620218 hasConcept C16685009 @default.
- W4381620218 hasConcept C179933525 @default.
- W4381620218 hasConcept C196843134 @default.
- W4381620218 hasConcept C2776283816 @default.
- W4381620218 hasConcept C2776537878 @default.
- W4381620218 hasConcept C2776690073 @default.
- W4381620218 hasConcept C2777688143 @default.
- W4381620218 hasConcept C2777904497 @default.
- W4381620218 hasConcept C2778278907 @default.
- W4381620218 hasConcept C2778279030 @default.
- W4381620218 hasConcept C2778459216 @default.
- W4381620218 hasConcept C2779234561 @default.
- W4381620218 hasConcept C2908647359 @default.
- W4381620218 hasConcept C29456083 @default.
- W4381620218 hasConcept C518429986 @default.
- W4381620218 hasConcept C54355233 @default.
- W4381620218 hasConcept C71924100 @default.
- W4381620218 hasConcept C86803240 @default.
- W4381620218 hasConcept C88972607 @default.
- W4381620218 hasConcept C99454951 @default.
- W4381620218 hasConceptScore W4381620218C105702510 @default.
- W4381620218 hasConceptScore W4381620218C126322002 @default.
- W4381620218 hasConceptScore W4381620218C160099875 @default.
- W4381620218 hasConceptScore W4381620218C16685009 @default.
- W4381620218 hasConceptScore W4381620218C179933525 @default.
- W4381620218 hasConceptScore W4381620218C196843134 @default.
- W4381620218 hasConceptScore W4381620218C2776283816 @default.
- W4381620218 hasConceptScore W4381620218C2776537878 @default.
- W4381620218 hasConceptScore W4381620218C2776690073 @default.
- W4381620218 hasConceptScore W4381620218C2777688143 @default.
- W4381620218 hasConceptScore W4381620218C2777904497 @default.
- W4381620218 hasConceptScore W4381620218C2778278907 @default.
- W4381620218 hasConceptScore W4381620218C2778279030 @default.
- W4381620218 hasConceptScore W4381620218C2778459216 @default.
- W4381620218 hasConceptScore W4381620218C2779234561 @default.
- W4381620218 hasConceptScore W4381620218C2908647359 @default.
- W4381620218 hasConceptScore W4381620218C29456083 @default.
- W4381620218 hasConceptScore W4381620218C518429986 @default.
- W4381620218 hasConceptScore W4381620218C54355233 @default.
- W4381620218 hasConceptScore W4381620218C71924100 @default.
- W4381620218 hasConceptScore W4381620218C86803240 @default.
- W4381620218 hasConceptScore W4381620218C88972607 @default.
- W4381620218 hasConceptScore W4381620218C99454951 @default.
- W4381620218 hasIssue "Supplement_1" @default.
- W4381620218 hasLocation W43816202181 @default.
- W4381620218 hasOpenAccess W4381620218 @default.
- W4381620218 hasPrimaryLocation W43816202181 @default.
- W4381620218 hasRelatedWork W2037827719 @default.
- W4381620218 hasRelatedWork W2078195589 @default.
- W4381620218 hasRelatedWork W2134057753 @default.
- W4381620218 hasRelatedWork W2151261872 @default.
- W4381620218 hasRelatedWork W2355794682 @default.
- W4381620218 hasRelatedWork W2378543141 @default.
- W4381620218 hasRelatedWork W2382050845 @default.
- W4381620218 hasRelatedWork W2584663557 @default.
- W4381620218 hasRelatedWork W2924128835 @default.
- W4381620218 hasRelatedWork W4243297511 @default.
- W4381620218 hasVolume "38" @default.
- W4381620218 isParatext "false" @default.
- W4381620218 isRetracted "false" @default.
- W4381620218 workType "article" @default.